SCHEDULE: Velan Capital Discloses InspireMD Stake

Velan Capital Master Fund LP and affiliated entities have reported beneficial ownership of 4.99% of InspireMD, Inc. common stock as of March 31, 2026.

Summary

• Velan Capital Master Fund LP, along with its general partner Velan Capital Holdings LLC, investment manager Velan Capital Investment Management LP, and its general partner Velan Capital Management LLC, along with individuals Adam Morgan and Balaji Venkataraman, have collectively reported beneficial ownership of InspireMD, Inc. common stock.
• As of March 31, 2026, the total beneficial ownership is 2,347,779 shares, representing 4.99% of the outstanding shares.
• This ownership includes shares directly held and shares underlying certain warrants, subject to beneficial ownership limitations.
• The filing is an amendment to a previous Schedule 13G, indicating a change or update in ownership reporting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It's a routine disclosure of ownership by an investment firm and does not inherently signal positive or negative performance for InspireMD, Inc.

Positives

• Velan Capital's reporting indicates a significant, though below 5%, stake in InspireMD, Inc., which could signal confidence in the company's prospects.
• The reporting is up-to-date as of March 31, 2026, providing current ownership information.

Negatives

• The beneficial ownership is capped at 4.99%, suggesting that the Reporting Persons may hold warrants that, if exercised beyond this limit, would require further filings or adjustments.
• The exclusion of shares issuable upon warrant exercise in excess of beneficial ownership limitations means the actual potential ownership could be higher but is currently restricted.

Risks

• The beneficial ownership limitations on warrants could lead to complex adjustments or future filings if these limitations are approached or exceeded.
• Potential for future increases in ownership, which could impact market dynamics if the 5% threshold is crossed.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a disclosure of beneficial ownership.

Management Comments

• Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein that he or it does not directly own.
• The filing of this Schedule 13G shall not be construed as an admission that the Reporting Persons are, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, the beneficial owners of any securities of the Issuer that he or it does not directly own.

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by Velan Capital indicates an active institutional investor monitoring and potentially accumulating a position in InspireMD, Inc. Such filings are common as investment firms adjust their portfolios and often precede significant corporate actions or market movements.

Stakeholder Impact

• Shareholders: May view the increased institutional interest as a positive sign, but the below-5% stake limits immediate impact on share price without further accumulation.
• Management: Will be aware of Velan Capital's stake and potential influence as a significant shareholder.

Next Steps

• Monitor future filings by Velan Capital for any changes in ownership, particularly if the 5% threshold is approached or exceeded.
• Observe InspireMD, Inc.'s corporate actions and financial performance for potential reasons behind Velan Capital's investment.

Key Dates

Keywords

InspireMD, Velan Capital, Schedule 13G, Beneficial Ownership, SEC Filing, Common Stock, Warrants, Investment Management